While Intuitive Surgical (ISRG -0.04%) has long been a Motley Fool favorite and a darling of the stock market, it has been a difficult month for the stock, coming down 5% and being targeted by short seller Citron Research. In this video, Motley Fool health care analyst David Williamson takes us through Wall Street's bullish stance on the stock, but also how Intuitive Surgical could be negatively affected by the pressure to lower health care costs.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Is Wall Street Right About Intuitive Surgical?
NASDAQ: ISRG
Intuitive Surgical

Is there an emerging bear case for Intuitive Surgical?
David Williamson has no position in any stocks mentioned. Follow him on Twitter @MotleyDavid. Max Macaluso has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned


*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.